![wiley wiley](https://cofactorgenomics.com/wp-content/uploads/2023/11/wiley-338x210.webp)
Multidimensional biomarker predicts disease control
In response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
![cof_press-journalmoleculardiagnostics cof_press-journalmoleculardiagnostics](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-journalmoleculardiagnostics-338x210.jpg)
JOURNAL OF MOLECULAR DIAGNOSTICS
Analytical Performance of an Immunoprofiling Assay Based on RNA Models
![cof_press-modernpathology cof_press-modernpathology](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-modernpathology-338x210.jpg)
MODERN PATHOLOGY
Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer
![aacr-clinical-cancer-research aacr-clinical-cancer-research](https://cofactorgenomics.com/wp-content/uploads/2022/04/aacr-clinical-cancer-research-338x210.png)
CLINICAL CANCER RESEARCH
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells
![cof_press-breast-cancerresearch cof_press-breast-cancerresearch](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-breast-cancerresearch-338x210.jpg)
BREAST CANCER RESEARCH AND TREATMENT
Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing
![cof_press-naturesr cof_press-naturesr](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-naturesr-338x210.jpg)
NATURE SCIENTIFIC METHODS
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response
![frontiers-in-oncology frontiers-in-oncology](https://cofactorgenomics.com/wp-content/uploads/2022/04/frontiers-in-oncology-338x210.jpeg)
FRONTIERS IN ONCOLOGY
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer
![cof_press-jitc cof_press-jitc](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-jitc-338x210.jpg)
JOURNAL OF IMMUNOTHERAPY FOR CANCER
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
![cof_press-journalradiationoncology cof_press-journalradiationoncology](https://cofactorgenomics.com/wp-content/uploads/2022/04/cof_press-journalradiationoncology-338x210.jpg)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY
A Multidimensional Gene Expression Model that Accurately Predicts Tumor Response to Pembrolizumab or Nivolumab
![jove jove](https://cofactorgenomics.com/wp-content/uploads/2022/04/jove.png)
JOURNAL OF VISUALIZED EXPERIMENTS
Predictive Immune Modeling of Solid Tumors